
School of Public Health News
The School of Public Health is dedicated to improving the health and well-being of people worldwide. Our departments, programs, and research units work to provide a diverse education, practical training experience, and numerous community involvement opportunities to prepare students to become leaders and professionals in the field of public health.
Current Public Health News
A collection of colorful headlines featuring UNLV staff and students.

UNLV Health Sciences schools team up with other state institutions to showcase faculty and student work.
Amanda Haboush-Deloye, 2025 Community-Based Research Award winner, works with community partners to get data about family well-being into the hands of decision makers.
Maria Palapa Vargas named 2025 Student Service Award winner for her work to provide lactation and nutrition support to families.
A group of faculty, students, and alumni roll out a campaign that encourages parents to complete their child's vaccine series.

A UNLV-record 28 graduate and professional programs placed within the nation’s top 100 in their discipline, including 14 from Boyd School of Law.
Public Health In The News

For years, Nevada has ranked among the lowest in the country for vaccination rates, and it’s getting worse.
Dr. Manoj Sharma, a Professor of Social and Behavioral Health and Internal Medicine, as well as President of Health for All, Inc., answers queries on caring for a loved one with epilepsy.
Methylene blue is a chemical that is used in treating methemoglobinemia, a rare disease in which hemoglobin in red blood cells has a reduced capacity to carry oxygen to the various parts of the body. It is also used in treating malaria with Plasmodium falciparum, drug-induced encephalopathy (a brain inflammation due to taking ifosfamide, a cancer treatment drug), and for diagnostic purposes, such as in examining the lymph nodes near the breast and parathyroid glands during their removal. It is also used as an antidote for nitrite or aniline poisoning.

As mosquito numbers rise, so does the risk of various diseases.
Vaxart’s orally administered vaccine tablet was safe and elicited mucosal immunity in older adults.
Imagine a world where acute gastroenteritis caused by norovirus—one of the most contagious viruses known to humankind—could be prevented with a simple tablet. With Vaxart’s innovative oral norovirus vaccine, we may be on the cusp of that reality. As norovirus continues to wreak havoc on public health, particularly among vulnerable populations, this breakthrough offers a ray of hope in the battle against viral infections.
Public Health Experts



